Lieve Verplancke
Director/Board Member bij MATERIALISE NV
Vermogen: - $ op 31-03-2024
Profiel
Lieve Verplancke was the founder of Qaly (founded in 2013) and Qaly-Co BV (founded in 2013), where she held the title of Managing Director from 2013 to 2020.
She currently holds the position of Independent Non-Executive Director at MDxHealth SA since 2017, Independent Director at Materialise NV since 2015, and Director at Fondation contre le Cancer.
Dr. Verplancke has also held former positions as Managing Director at Merck & Co., Inc., Director at Euronext Brussels SA, Independent Director at Quest for Growth NV, Managing Director at Bristol-Myers Squibb Belgium SA, Director at Stichting Tegen Kanker, and Director at Imelda Hospital.
Dr. Verplancke obtained a doctorate degree from Katholieke Universiteit Leuven and holds graduate and MBA degrees from the University of Antwerp.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MDXHEALTH S.A.
-.--% | 31-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Lieve Verplancke
| Bedrijven | Functie | Begin |
|---|---|---|
| MATERIALISE NV | Director/Board Member | 09-06-2015 |
| MDXHEALTH SA | Director/Board Member | 26-05-2017 |
| Fondation contre le Cancer | Director/Board Member | - |
Eerdere bekende functies van Lieve Verplancke
| Bedrijven | Functie | Einde |
|---|---|---|
| Qaly-Co BV | Founder | 01-01-2020 |
| Qaly | Chief Executive Officer | 01-01-2020 |
Bristol-Myers Squibb Belgium SA
 Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The private company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Corporate Officer/Principal | 01-01-2012 |
| Stichting Tegen Kanker | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Opleiding van Lieve Verplancke
| Katholieke Universiteit Leuven | Doctorate Degree |
| University of Antwerp | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MDXHEALTH SA | Health Technology |
| MATERIALISE NV | Technology Services |
| Bedrijven in privébezit | 8 |
|---|---|
Euronext Brussels SA/NV
 Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Finance |
Quest for Growth NV
 Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It focuses on innovative companies in areas such as digital technologies (ICT), technologies for the healthcare sector (Health-tech) and clean technology (Cleantech). | Finance |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The private company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Health Technology |
| Stichting Tegen Kanker | Miscellaneous |
| Qaly | |
| Imelda Hospital | |
| Fondation contre le Cancer | Miscellaneous |
| Qaly-Co BV |
